LGLVX
Price
$57.34
Change
+$0.88 (+1.56%)
Updated
Aug 22 closing price
Net Assets
7.78B
RGACX
Price
$82.18
Change
+$1.56 (+1.94%)
Updated
Aug 22 closing price
Net Assets
328.96B
Interact to see
Advertisement

LGLVX vs RGACX

Header iconLGLVX vs RGACX Comparison
Open Charts LGLVX vs RGACXBanner chart's image
Lord Abbett Growth Leaders R6
Price$57.34
Change+$0.88 (+1.56%)
VolumeN/A
Net Assets7.78B
American Funds Growth Fund of Amer R3
Price$82.18
Change+$1.56 (+1.94%)
VolumeN/A
Net Assets328.96B
LGLVX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LGLVX vs. RGACX commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGLVX is a StrongBuy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 329B vs. LGLVX (7.78B). RGACX pays higher dividends than LGLVX: RGACX (0.07) vs LGLVX (0.00). LGLVX was incepted earlier than RGACX: LGLVX (10 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than LGLVX (0.59). LGLVX is a more actively managed with annual turnover of: 94.00 vs. RGACX (25.00). LGLVX has a lower initial minimum investment than RGACX: LGLVX (0) vs RGACX (250). LGLVX annual gain was more profitable for investors over the last year : 34.79 vs. RGACX (14.04). RGACX return over 5 years is better than : 39.56 vs. LGLVX (35.14).
LGLVXRGACXLGLVX / RGACX
Total Expense Ratio0.590.9463%
Annual Report Gross Expense Ratio0.590.9463%
Fund Existence10 years23 years-
Gain YTD14.33714.155101%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets7.78B329B2%
Annual Yield % from dividends0.000.07-
Returns for 1 year34.7914.04248%
Returns for 3 years83.0248.43171%
Returns for 5 years35.1439.5689%
Returns for 10 years165.96104.21159%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EUDA2.600.17
+6.91%
EUDA Health Holdings Limited
YRD6.160.12
+1.99%
Yiren Digital Ltd
OGN9.430.15
+1.62%
Organon & Co
FMS25.600.34
+1.35%
Fresenius Medical Care AG
PMCB0.970.01
+1.04%
PharmaCyte Biotech